• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用质子磁共振波谱法鉴别多系统萎缩与特发性帕金森病

Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.

作者信息

Davie C A, Wenning G K, Barker G J, Tofts P S, Kendall B E, Quinn N, McDonald W I, Marsden C D, Miller D H

机构信息

Department of Clinical Neurology, Institute of Neurology, London, UK.

出版信息

Ann Neurol. 1995 Feb;37(2):204-10. doi: 10.1002/ana.410370211.

DOI:10.1002/ana.410370211
PMID:7847862
Abstract

Proton magnetic resonance spectroscopy, localized to the lentiform nucleus, was carried out in 7 patients with the pure or predominantly striatonigral variant (SND) of multiple system atrophy (MSA), 5 patients with the olivopontocerebellar variant of MSA, 9 patients with a clinical diagnosis of idiopathic Parkinson's disease (IPD), and 9 healthy age-matched controls. The MSA group with predominantly striatonigral involvement showed a significant reduction in the N-acetylaspartate (NAA)/creatine ratio (median, 1.19; range, 0.96-2.0; p < 0.02) compared with the NAA/creatine ratio from the control group (median, 1.76; range, 1.61-2.0). In contrast, the IPD group had a normal NAA/creatine ratio (median, 1.82; range, 1.19-2.31; p > 0.05). The NAA/creatine ratio was markedly reduced in 6 of the SND patients and in only 1 IPD patient. The choline/creatine ratio was also significantly lower in the SND group (median, 1.02; range, 0.91-1.23; p < 0.04) compared with the control group (median, 1.22; range, 1.05-1.65). The IPD group showed a normal lentiform choline/creatine ratio (median, 1.13; range, 0.89-1.65; p = 0.25) compared with controls. The olivopontocerebellar group also showed a significant reduction in the NAA/creatine ratio from the lentiform nucleus (median, 1.47; range, 1.22-1.68; p < 0.01) compared with the controls as well as a nonsignificant reduction in the choline/creatine ratio (median, 0.93; range, 0.85-1.27; p < 0.4).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对7例患有纯或主要为纹状体黑质变性型(SND)的多系统萎缩(MSA)患者、5例橄榄脑桥小脑型MSA患者、9例临床诊断为特发性帕金森病(IPD)的患者以及9例年龄匹配的健康对照者进行了定位在豆状核的质子磁共振波谱分析。主要累及纹状体黑质的MSA组与对照组的N-乙酰天门冬氨酸(NAA)/肌酸比值相比(对照组中位数为1.76,范围1.61 - 2.0;MSA组中位数为1.19,范围0.96 - 2.0;p < 0.02),NAA/肌酸比值显著降低。相比之下,IPD组的NAA/肌酸比值正常(中位数为1.82,范围1.19 - 2.31;p > 0.05)。6例SND患者和仅1例IPD患者的NAA/肌酸比值明显降低。与对照组相比,SND组的胆碱/肌酸比值也显著降低(对照组中位数为1.22,范围1.05 - 1.65;SND组中位数为1.02,范围0.91 - 1.23;p < 0.04)。与对照组相比,IPD组豆状核的胆碱/肌酸比值正常(中位数为1.13,范围0.89 - 1.65;p = 0.25)。橄榄脑桥小脑组与对照组相比,豆状核的NAA/肌酸比值也显著降低(中位数为1.47,范围1.22 - 1.68;p < 0.01),胆碱/肌酸比值虽有降低但无统计学意义(中位数为0.93,范围0.85 - 1.27;p < 0.4)。(摘要截断于250字)

相似文献

1
Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.利用质子磁共振波谱法鉴别多系统萎缩与特发性帕金森病
Ann Neurol. 1995 Feb;37(2):204-10. doi: 10.1002/ana.410370211.
2
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.帕金森病和非典型帕金森综合征中的质子磁共振波谱分析
Mov Disord. 1997 Nov;12(6):903-9. doi: 10.1002/mds.870120611.
3
Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome.
Mov Disord. 1997 Sep;12(5):767-71. doi: 10.1002/mds.870120525.
4
Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.采用质子磁共振波谱法测定特发性帕金森病患者基底节区N-乙酰天门冬氨酸和谷氨酸含量未发生改变。
Mov Disord. 1997 May;12(3):297-301. doi: 10.1002/mds.870120306.
5
Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.系统性红斑狼疮中可逆性轴突功能障碍的证据:一项质子磁共振波谱研究。
Brain. 2005 Dec;128(Pt 12):2933-40. doi: 10.1093/brain/awh646. Epub 2005 Sep 29.
6
MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.拉福拉病患者脑部的磁共振成像容积分析和质子磁共振波谱分析
Epilepsia. 2006 Apr;47(4):788-92. doi: 10.1111/j.1528-1167.2006.00526.x.
7
[Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].帕金森病和多系统萎缩中的磁共振波谱分析
Nihon Rinsho. 1997 Jan;55(1):249-54.
8
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.阿尔茨海默病颞叶的体内质子磁共振波谱分析
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1313-22. doi: 10.1016/j.pnpbp.2004.08.013.
9
Brainstem 1H-MR spectroscopy in patients with Parkinson's disease with REM sleep behavior disorder and IPD patients without dream enactment behavior.帕金森病伴快速眼动睡眠行为障碍患者及无梦境演绎行为的特发性帕金森病患者的脑干1H-磁共振波谱分析
Clin Neurol Neurosurg. 2006 Feb;108(2):129-34. doi: 10.1016/j.clineuro.2005.03.011. Epub 2005 Jun 3.
10
Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.“单纯型”肾上腺脑白质营养不良患者脑轴索性病变的光谱学证据
Neurology. 2005 Jan 25;64(2):304-10. doi: 10.1212/01.WNL.0000149514.13580.84.

引用本文的文献

1
A comparative study of posterior cingulate metabolism in patients with mild cognitive impairment due to Parkinson's disease or Alzheimer's disease.帕金森病或阿尔茨海默病所致轻度认知障碍患者后扣带回代谢的对比研究。
Sci Rep. 2023 Aug 30;13(1):14241. doi: 10.1038/s41598-023-41569-5.
2
Magnetic resonance imaging for the diagnosis of Parkinson's disease.用于帕金森病诊断的磁共振成像
J Neural Transm (Vienna). 2017 Aug;124(8):915-964. doi: 10.1007/s00702-017-1717-8. Epub 2017 Apr 4.
3
Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update.
脑磁共振成像对帕金森综合征鉴别诊断的贡献:最新进展
Parkinsons Dis. 2016;2016:2983638. doi: 10.1155/2016/2983638. Epub 2016 Sep 28.
4
Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease.帕金森病中纹状体小脑代谢改变与全身炎症
Oxid Med Cell Longev. 2016;2016:1810289. doi: 10.1155/2016/1810289. Epub 2016 Sep 1.
5
Magnetic resonance imaging markers for early diagnosis of Parkinson's disease.用于帕金森病早期诊断的磁共振成像标志物。
Neural Regen Res. 2012 Mar 15;7(8):611-9. doi: 10.3969/j.issn.1673-5374.2012.08.009.
6
Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease?磁共振波谱:帕金森病的一种体内分子成像生物标志物?
Biomed Res Int. 2014;2014:519816. doi: 10.1155/2014/519816. Epub 2014 Sep 11.
7
Metabolic changes detected by ex vivo high resolution 1H NMR spectroscopy in the striatum of 6-OHDA-induced Parkinson's rat.6-OHDA 诱导的帕金森病大鼠纹状体中海马 1H-NMR 代谢组学研究。
Mol Neurobiol. 2013 Feb;47(1):123-30. doi: 10.1007/s12035-012-8336-z. Epub 2012 Aug 31.
8
A molecular signature in blood identifies early Parkinson's disease.血液中的分子特征可识别早期帕金森病。
Mol Neurodegener. 2012 May 31;7:26. doi: 10.1186/1750-1326-7-26.
9
Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism.磁共振磁敏感加权成像在鉴别帕金森病与非典型帕金森综合征中的作用。
Neuroradiology. 2010 Dec;52(12):1087-94. doi: 10.1007/s00234-010-0677-6. Epub 2010 Apr 1.
10
MR spectroscopy in neurodegenerative disease.神经退行性疾病中的磁共振波谱分析
Mol Imaging Biol. 2007 Jul-Aug;9(4):196-203. doi: 10.1007/s11307-007-0087-2.